20/20 Biolabs

AIDXNasdaq United States Health Care Precision Instruments

Market cap

$6.008 M

$0.47 +0.13%

Close of 22 Sept 2026

Revenue

$2.05M

#3412 by revenue

Earnings

-$3.74M

Loss-making

Shares outstanding

10,611,528

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Precision Instruments, ranked by market cap

All 3 →

#1UL SolutionsULS$13.5B
#2NeogenomicsNEO$2.43B
#320/20 BiolabsAIDX$6.01M

What if 20/20 Biolabs were worth as much as…

Open the what-if tool →

Gold $30.2T

$2,367,522

Per share 5,031,927× higher

Bitcoin $1.74T

$136,383.21

Per share 289,869× higher

Nvidia $5.52T

$431,921.36

Per share 918,005× higher

Or at a round number

$10.0M $20.0M $50.0M $100.0M

Where these numbers come from

Share counts and financials for 20/20 Biolabs are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 23 Sept 2026. Read the methodology.